The weight loss drug revolution is here, driven by Big Pharma with new drugs like Ozempic, Wegovy, semaglutide, and tirzepatide being marketed as the solution to national obesity. While effective, at $1,500 a month, these drugs may not always be the best first option. Older, cheaper medications have shown similar success. In this episode, we discuss "sequential polypharmacy"—using different drugs as your body adapts, continuing weight loss success. We’ll also explore side effects and how to avoid them, along with the debate between wild vs. farmed salmon and disturbing water safety news.